Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TFPI | P10646 | 1/20 | 0.61 |
| ▸ | VIPR1 | P32241 | 4/20 | 0.59 |
| ▸ | GLP1R | P43220 | 4/20 | 0.59 |
| ▸ | VIPR2 | P41587 | 5/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30436623 | 0.91 | VIPR1 (0.63) | TFPIVIPR1GLP1RVIPR2 | |
| SCHEMBL31688322 | 0.91 | VIPR2 (0.57) | TFPIVIPR1GLP1RVIPR2 | |
| SCHEMBL10694201 | 0.90 | BACE1 (0.60) | TFPIVIPR1GLP1RVIPR2 | |
| SCHEMBL30567445 | 0.90 | TFPI (0.61) | TFPIVIPR1GLP1RVIPR2 | |
| SCHEMBL30387150 | 0.90 | VIPR2 (0.62) | TFPIVIPR1GLP1RVIPR2 | |
| SCHEMBL30495833 | 0.90 | OPRL1 (0.58) | TFPIVIPR1GLP1RVIPR2 | |
| SCHEMBL31182852 | 0.90 | TFPI (0.59) | TFPIVIPR1GLP1RVIPR2 | |
| SCHEMBL30712924 | 0.89 | TFPI (0.61) | TFPIVIPR1VIPR2 | |
| SCHEMBL29376362 | 0.89 | TFPI (0.66) | TFPIVIPR1GLP1R | |
| SCHEMBL30168728 | 0.89 | TFPI (0.58) | TFPIVIPR1GLP1RVIPR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4644390-A1 | PROTEIN TYROSINE KINASE INHIBITOR AND MEDICAL USE THEREOF | Beyang Therapeutics Co., Ltd. (CN) | 2025-11-05 | — | — | EP | claimed |
| WO-2024140850-A1 | PROTEIN TYROSINE KINASE INHIBITOR AND MEDICAL USE THEREOF | 苏州必扬医药科技有限公司 | 2024-07-04 | — | — | WO | claimed |
| US-12635401-B2 | Metal complexes | UDC Ireland (IE) | 2026-05-19 | — | — | US | disclosed |
| US-12479873-B2 | Metal complexes | UDC Ireland (IE) | 2025-11-25 | — | — | US | disclosed |
| EP-4644390-A1 | PROTEIN TYROSINE KINASE INHIBITOR AND MEDICAL USE THEREOF | Beyang Therapeutics Co., Ltd. (CN) | 2025-11-05 | — | — | EP | disclosed |
| EP-4069709-B1 | METAL COMPLEXES | UDC IRELAND LTD (IE) | 2025-04-23 | — | — | EP | disclosed |
| WO-2024140850-A1 | PROTEIN TYROSINE KINASE INHIBITOR AND MEDICAL USE THEREOF | 苏州必扬医药科技有限公司 | 2024-07-04 | — | — | WO | disclosed |
| WO-2024075396-A1 | EXPOSURE METHOD AND EXPOSURE DEVICE | 株式会社ニコン | 2024-04-11 | — | — | WO | disclosed |
| US-20230322826-A1 | METAL COMPLEXES | UDC IRELAND LIMITED (IE) | 2023-10-12 | — | — | US | disclosed |
| US-11713332-B2 | Metal complexes | MERCK PATENT GMBH (DE) | 2023-08-01 | — | — | US | disclosed |
| US-20230121182-A1 | IMAGE PROCESSING APPARATUS, IMAGE PROCESSING METHOD, IMAGE PROCESSING PROGRAM, AND RECORDING MEDIUM STORING PROGRAM | FUJIFILM CORPORATION (JP) | 2023-04-20 | — | — | US | disclosed |
| US-20230056324-A1 | METAL COMPLEXES | MERCK PATENT GMBH (DE) | 2023-02-23 | — | — | US | disclosed |
| WO-2023286582-A1 | COMPOSITION, FILM, OPTICAL FILTER, SOLID-STATE IMAGING ELEMENT, IMAGE DISPLAY DEVICE, INFRARED SENSOR, CAMERA MODULE, AND COMPOUND | 富士フイルム株式会社 | 2023-01-19 | — | — | WO | disclosed |
| US-11556582-B2 | Image processing apparatus, image processing method, image processing program, and recording medium storing program | FUJIFILM CORPORATION (JP) | 2023-01-17 | — | — | US | disclosed |
| EP-3487865-B1 | DINUCLEAR AND OLIGONUCLEAR METAL COMPLEXES CONTAINING TRIPODAL BIDENTATE PART LIGANDS AND THEIR USE IN ELECTRONIC DEVICES | MERCK PATENT GMBH (DE) | 2022-11-23 | — | — | EP | disclosed |
| US-11437592-B2 | Dinuclear and oligonuclear metal complexes containing tripodal bidentate part ligands and their use in electronic devices | MERCK PATENT GMBH (DE) | 2022-09-06 | — | — | US | disclosed |
| US-11404649-B2 | Electroluminescent bridged metal complexes for use in electronic devices | MERCK PATENT GMBH (DE) | 2022-08-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12635401-B2 | Metal complexes | SCO2, SOD1, NR4A1 | TFPI 4337/4885VIPR1 2026/4885GLP1R 2504/4885 |
| US-12479873-B2 | Metal complexes | AP1M1, SOD1, AP3M1 | TFPI 2275/4885VIPR1 4307/4885GLP1R 4876/4885 |
| US-20230056324-A1 | METAL COMPLEXES | MCU, IMMT, SOD1 | TFPI 3362/4885VIPR1 2734/4885GLP1R 4773/4885 |
| US-11404649-B2 | Electroluminescent bridged metal complexes for use in electronic devices | MCOLN2, MCOLN1, NCLN | TFPI 3065/4885VIPR1 3798/4885GLP1R 4693/4885 |
| US-11713332-B2 | Metal complexes | AP1M1, SOD1, AP3M1 | TFPI 2275/4885VIPR1 4307/4885GLP1R 4876/4885 |
| US-20230322826-A1 | METAL COMPLEXES | AP1M1, SOD1, AP3M1 | TFPI 2275/4885VIPR1 4307/4885GLP1R 4876/4885 |
| US-11437592-B2 | Dinuclear and oligonuclear metal complexes containing tripodal bidentate part ligands and their use in electronic devices | SSBP1, POLRMT, BICRA | TFPI 3595/4885VIPR1 1406/4885GLP1R 4486/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.